Established in 2023, Genome Technologies Limited (GTL) is a spin-off biotechnology company of the Centre for Translational Stem Cell Biology with patented advanced genome editing technology.
Specializing in AI-assisted sgRNA design, efficient electroporation and ES cell injection technologies, Genome Technologies Limited (GTL) is determined to reduce the social cost for academic institutions and clinical therapeutic drug/ antibody discovery enterprises by providing highly efficient genome editing services.

As a member of the HKSTP Incu-Bio Programme, GTL is connected with a wide variety of multinational experts from different areas, offering mentorship, coaching, strategy, skills and knowledge.

The Technology Startup Support Scheme for Universities at HKU (TSSSU@HKU) aims to foster entrepreneurship within the HKU community. This scheme provides strong funding support to encourage technology start-ups.
As an awardee of TSSSU@HKU, GTL is connected to an extensive network of community while also gaining public exposure opportunities in various areas.

GTL has established comprehensive experimental animal research centers in Hong Kong, Shenzhen and Chongqing that includes a small animal breeding center focused on mice and a large animal breeding center focused on pigs.
These facilities are well equipped with a wide variety of apparatus and experts to provide customers with efficient and comprehensive services.

GTL aims to help researchers obtain high-quality model animals quickly, while providing support for scientific research and therapeutic development using our precise and efficient gene editing technology.